Calcineurin Inhibitor-Free Mycophenolate Mofetil/Sirolimus Maintenance in Liver Transplantation: The Randomized Spare-the-Nephron Trial

Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial

(2012) M. F. Abdelmalek et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function

(2010) M. Masetti et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis

(2010) Sumeet K. Asrani et al.   HEPATOLOGY

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

(2010) Matthew R. Weir et al.   KIDNEY INTERNATIONAL

A Clinical Review of Statins and Cancer: Helpful or Harmful?

(2010) Michael J Gonyeau et al.   PHARMACOTHERAPY

Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids

(2010) Denis Glotz et al.   TRANSPLANTATION

Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial

(2010) Markus Guba et al.   TRANSPLANTATION

Tubular Toxicity in Sirolimus- and Cyclosporine-Based Transplant Immunosuppression Strategies: An Ancillary Study From a Randomized Controlled Trial

(2009) Stefan Franz et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients

(2009) Christin C. Rogers et al.   CLINICAL TRANSPLANTATION

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma

(2009) Christian Toso et al.   HEPATOLOGY

Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

(2009) Srinath Chinnakotla et al.   LIVER TRANSPLANTATION

mTOR regulates memory CD8 T-cell differentiation

(2009) Koichi Araki et al.   NATURE

Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients

(2009) Michele Molinari et al.   TRANSPLANT INTERNATIONAL

Safety of an Immunosuppressant Protocol Based on Sirolimus in Liver Transplant Recipients With Malignancies or High Risk of Tumor Recurrence

(2009) J.F. Castroagudín et al.   TRANSPLANTATION PROCEEDINGS

Liver and Intestine Transplantation in the United States, 1997–2006

(2008) R. B. Freeman et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Statins in tumor suppression

(2008) Antonella Sassano et al.   CANCER LETTERS

Statins and cancer: A systematic review and meta-analysis

(2008) Jaana Kuoppala et al.   EUROPEAN JOURNAL OF CANCER

Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma

(2008) Zheng Wang et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma

(2008) Michael A. Zimmerman et al.   LIVER TRANSPLANTATION

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

(2008) Derek DuBay et al.   LIVER TRANSPLANTATION

Calcineurin inhibitor minimization protocols in liver transplantation

(2008) Stefan A. Farkas et al.   TRANSPLANT INTERNATIONAL

The Impact of mTOR Inhibitors on the Development of Malignancy

(2008) E.K. Geissler   TRANSPLANTATION PROCEEDINGS

Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria

(2008) J. Zhou et al.   TRANSPLANTATION PROCEEDINGS

mToR inhibitors-induced proteinuria: mechanisms, significance, and management

(2008) Emmanuel Letavernier et al.   Transplantation Reviews